Jorge A. García

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci et al. · New England Journal of Medicine · 2015 · 2.7K citations · Full text

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Christos E. Kyriakopoulos, Yu‐Hui Chen, Michael A. Carducci et al. · Journal of Clinical Oncology · 2018 · 1.1K citations

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

Andrew J. Armstrong, Susan Halabi, Tim Eisen et al. · The Lancet Oncology · 2016 · 420 citations

Urology, Genitourinary Cancer, Medicine +6

Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Homayoun Zargar, Patrick Espiritu, Adrian Fairey et al. · European Urology · 2014 · 296 citations · Full text

Urology, Genitourinary Cancer, Medicine +2

Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer

Zhenfei Li, Andrew C. Bishop, Mohammad Alyamani et al. · Nature · 2015 · 251 citations · Full text

Urology, Oncology, Medicine +7